Target |
Mechanism thrombin inhibitors |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism thrombin inhibitors |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date27 Oct 2020 |
Sponsor / Collaborator |
Start Date01 Jul 2015 |
Sponsor / Collaborator |
Start Date07 Jul 2014 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
TRIB-50 ( thrombin ) | Thrombosis More | Discontinued |
TRI-25 | Thrombosis More | Pending |
TRI-166 ( thrombin ) | Thrombosis More | Pending |